Form 4: Fulgent Genetics COO Sells Shares to Cover Tax Obligations

Fulgent Genetics' President and COO, Jian Xie, sold 689 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Jian Xie, the President and COO of Fulgent Genetics, sold 689 shares of common stock on November 25, 2024.
• The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 23, 2023.
• The shares were sold at a weighted-average price of $18.2593, with individual transaction prices ranging from $18.12 to $18.50.
• Following the transaction, Mr. Xie directly owns 336,136 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance or future prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• The sale of 689 shares is relatively small compared to the total holdings of the executive, which is not unusual for tax-related sales.
• The price range of $18.12 to $18.50 is within the normal trading range for the stock.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

Fulgent Genetics, Jian Xie, stock sale, insider trading, tax obligations, restricted stock units, FLGT